Cross-Sector entity
clinical-trial is the sole category represented across all 1 tracked stories. Mei is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Gene-editing therapy appears in 1 tracked Cross-Sector story from July 26, 2026.
1 verified story tracked
Last mentioned: Jul 26, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
clinical-trial is the sole category represented across all 1 tracked stories. Mei is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Gene-editing therapy appears in 1 tracked Cross-Sector story from July 26, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Gene-editing therapy. Shared-story counts are live from our verified record — not editorial picks.
University investigation launched
Shanghai Jiao Tong University School of Medicine announces a special working group to investigate and promises 'serious action'.
Investigative report published
Science and Retraction Watch publish a joint exposé revealing the death and lack of disclosure, triggering international scrutiny.
Mei receives gene-editing therapy
Six-year-old girl with rare cognitive delay condition receives spinal infusion of trillions of engineered viruses in an experimental trial.
The death of a young patient in a Chinese gene-editing trial, hidden from a subsequent Nature publication, sends shockwaves through the biotech sector. Industry leaders must grapple with the implications for gene therapy research integrity, funding, and the race to deliver transformative neurological treatments.
Source: channelnewsasia.com · straitstimes.com
